The Effects of Schema Therapy in Outpatient Forensic Mental Health Care: a Single Case Multiple-baseline Study.

Launched by VRIJE UNIVERSITEIT BRUSSEL · Aug 30, 2022

Keywords

ClinConnect Summary

This clinical trial is investigating the effects of Schema Therapy (ST) on patients with personality disorders (PDs) in outpatient forensic mental health settings. The goal is to see if this therapy can help reduce the risk of reoffending and improve patients' overall mental health. The study will look at how patients' thought patterns change, whether they become less likely to commit crimes again, and if a specific way of measuring personality functioning can help track their progress throughout the treatment.

To participate in the trial, individuals must be diagnosed with a personality disorder and agree to receive Schema Therapy. They should be willing to give their consent to join the study. However, people with certain conditions, such as low IQ, current severe mental health issues like psychosis or bipolar disorder, or those who are sex offenders, will not be eligible. This study is unique because it focuses on outpatient care, meaning that patients will not be required to stay in a hospital but will receive treatment while living in the community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with a PD who have been diagnosed with the SCID-5-PD
• • patients who will receive ST for their PD
• • and are willing to sign informed consent to participate in the study.
• Exclusion Criteria:
• • patients with an IQ lower than 80
• • patients with actual psychosis
• • patients with actual bipolar problems
• • patients having a severe addiction
• • sex offenders
• • patients who can be involuntary admitted in psychiatric hospital when they do not cooperate in treatment ("TBS met voorwaarden").